HEADER HYDROLASE/HYDROLASE INHIBITOR 31-DEC-11 3VB4 TITLE CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH B4Z COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: B4Z INHIBITOR; COMPND 9 CHAIN: E, F; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS; SOURCE 3 ORGANISM_COMMON: SARS-COV; SOURCE 4 ORGANISM_TAXID: 227859; SOURCE 5 GENE: 1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: SYNTHETIC INHIBITOR KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.P.CHUCK,K.B.WONG REVDAT 3 06-DEC-23 3VB4 1 REMARK REVDAT 2 08-NOV-23 3VB4 1 REMARK LINK REVDAT 1 12-DEC-12 3VB4 0 JRNL AUTH C.P.CHUCK,C.CHEN,Z.KE,D.C.-C.WAN,H.F.CHOW,K.B.WONG JRNL TITL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF JRNL TITL 2 NITRILE-BASED BROAD-SPECTRUM PEPTIDOMIMETIC INHIBITORS FOR JRNL TITL 3 CORONAVIRUS 3C-LIKE PROTEASES JRNL REF EUR.J.MED.CHEM. V. 59C 1 2012 JRNL REFN ISSN 0223-5234 JRNL PMID 23202846 JRNL DOI 10.1016/J.EJMECH.2012.10.053 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.430 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 33309 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.8198 - 5.2954 0.99 2267 144 0.2201 0.2407 REMARK 3 2 5.2954 - 4.2059 1.00 2253 144 0.1660 0.2169 REMARK 3 3 4.2059 - 3.6751 1.00 2253 144 0.1719 0.2200 REMARK 3 4 3.6751 - 3.3394 1.00 2242 143 0.1562 0.2084 REMARK 3 5 3.3394 - 3.1003 1.00 2235 142 0.1629 0.2138 REMARK 3 6 3.1003 - 2.9176 1.00 2224 142 0.1650 0.2334 REMARK 3 7 2.9176 - 2.7715 1.00 2229 142 0.1713 0.2308 REMARK 3 8 2.7715 - 2.6510 1.00 2266 145 0.1766 0.2564 REMARK 3 9 2.6510 - 2.5489 1.00 2218 142 0.1851 0.2658 REMARK 3 10 2.5489 - 2.4610 1.00 2216 141 0.1900 0.2534 REMARK 3 11 2.4610 - 2.3841 1.00 2246 144 0.2003 0.2519 REMARK 3 12 2.3841 - 2.3160 1.00 2212 141 0.2208 0.3016 REMARK 3 13 2.3160 - 2.2550 1.00 2219 142 0.2191 0.2820 REMARK 3 14 2.2550 - 2.2000 1.00 2232 141 0.2435 0.3138 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 42.86 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.63460 REMARK 3 B22 (A**2) : 6.41740 REMARK 3 B33 (A**2) : -5.78280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.86160 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4924 REMARK 3 ANGLE : 1.077 6679 REMARK 3 CHIRALITY : 0.069 755 REMARK 3 PLANARITY : 0.004 863 REMARK 3 DIHEDRAL : 14.344 1782 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VB4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000069822. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33359 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 34.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: PDB ENTRY 2Q6G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8.5% PEG 6000, 0.1M MES, 1MM DTT, 1MM REMARK 280 EDTA, 3% DMSO, 10% GLYCEROL, PH 5.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.55150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE B4Z INHIBITOR IS PEPTIDE-LIKE, A MEMBER OF ENZYME INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: B4Z INHIBITOR REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 534 O HOH B 605 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 503 O HOH B 605 1455 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -116.66 55.64 REMARK 500 HIS A 41 4.87 -67.56 REMARK 500 ASN A 51 72.00 -152.23 REMARK 500 ASN A 84 -123.42 58.13 REMARK 500 TYR A 154 -111.74 54.99 REMARK 500 PRO A 184 45.70 -90.71 REMARK 500 ARG A 217 -4.91 -140.18 REMARK 500 ASN A 277 72.90 52.60 REMARK 500 ASP B 33 -128.14 47.20 REMARK 500 HIS B 41 1.19 -67.93 REMARK 500 ALA B 46 -139.38 48.13 REMARK 500 ASN B 84 -122.79 51.64 REMARK 500 TYR B 154 -93.83 54.61 REMARK 500 GLN B 189 47.16 -78.62 REMARK 500 ARG B 217 20.26 -140.08 REMARK 500 ASN B 238 34.81 70.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF B4Z INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF B4Z INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3VB3 RELATED DB: PDB REMARK 900 RELATED ID: 3VB5 RELATED DB: PDB REMARK 900 RELATED ID: 3VB6 RELATED DB: PDB REMARK 900 RELATED ID: 3VB7 RELATED DB: PDB DBREF 3VB4 A 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3VB4 B 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3VB4 E 1 5 PDB 3VB4 3VB4 1 5 DBREF 3VB4 F 1 5 PDB 3VB4 3VB4 1 5 SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 A 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 B 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 B 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 B 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 B 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 B 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 B 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 B 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 B 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 B 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 B 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 B 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 B 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 B 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 B 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 B 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 B 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 B 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 B 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 B 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 B 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 B 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 E 5 BOC ALA VAL LEU 0JU SEQRES 1 F 5 BOC ALA VAL LEU 0JU HET BOC E 1 7 HET 0JU E 5 9 HET BOC F 1 7 HET 0JU F 5 9 HET EDO A 401 4 HET EDO A 402 4 HET EDO A 403 4 HET EDO B 401 4 HET EDO B 402 4 HET EDO B 403 4 HET GOL B 404 6 HET EDO B 405 4 HET EDO B 406 4 HETNAM BOC TERT-BUTYL HYDROGEN CARBONATE HETNAM 0JU (4S,5Z)-4-AMINO-5-IMINOPENTANAMIDE HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 BOC 2(C5 H10 O3) FORMUL 3 0JU 2(C5 H11 N3 O) FORMUL 5 EDO 8(C2 H6 O2) FORMUL 11 GOL C3 H8 O3 FORMUL 14 HOH *201(H2 O) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 CYS A 44 5 4 HELIX 3 3 ALA A 46 LEU A 50 5 5 HELIX 4 4 ASN A 53 ARG A 60 1 8 HELIX 5 5 SER A 62 HIS A 64 5 3 HELIX 6 6 ILE A 200 ASN A 214 1 15 HELIX 7 7 THR A 226 MET A 235 1 10 HELIX 8 8 LYS A 236 ASN A 238 5 3 HELIX 9 9 THR A 243 LEU A 250 1 8 HELIX 10 10 LEU A 250 GLY A 258 1 9 HELIX 11 11 ALA A 260 GLY A 275 1 16 HELIX 12 12 THR A 292 SER A 301 1 10 HELIX 13 13 SER B 10 GLY B 15 1 6 HELIX 14 14 HIS B 41 CYS B 44 5 4 HELIX 15 15 THR B 45 ASN B 51 5 7 HELIX 16 16 ASN B 53 LYS B 61 1 9 HELIX 17 17 SER B 62 PHE B 66 5 5 HELIX 18 18 ILE B 200 ASN B 214 1 15 HELIX 19 19 THR B 226 MET B 235 1 10 HELIX 20 20 LYS B 236 ASN B 238 5 3 HELIX 21 21 THR B 243 LEU B 250 1 8 HELIX 22 22 LEU B 250 GLY B 258 1 9 HELIX 23 23 ALA B 260 GLY B 275 1 16 HELIX 24 24 THR B 292 SER B 301 1 10 SHEET 1 A 7 VAL A 73 LEU A 75 0 SHEET 2 A 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 A 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 A 7 THR A 25 LEU A 32 -1 O THR A 25 N CYS A 22 SHEET 5 A 7 THR A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 A 7 LEU A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 A 7 VAL A 77 GLN A 83 -1 N SER A 81 O ARG A 88 SHEET 1 B 3 LYS A 100 PHE A 103 0 SHEET 2 B 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 B 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 C 5 SER A 121 ALA A 129 0 SHEET 2 C 5 THR A 111 TYR A 118 -1 N ALA A 116 O SER A 123 SHEET 3 C 5 VAL A 148 ASP A 153 -1 O PHE A 150 N SER A 113 SHEET 4 C 5 CYS A 156 GLU A 166 -1 O SER A 158 N ASN A 151 SHEET 5 C 5 VAL E 3 LEU E 4 -1 O VAL E 3 N GLU A 166 SHEET 1 D 7 VAL B 73 LEU B 75 0 SHEET 2 D 7 LEU B 67 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 D 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 D 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 D 7 THR B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 LEU B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 D 7 VAL B 77 GLN B 83 -1 N SER B 81 O ARG B 88 SHEET 1 E 3 LYS B 100 PHE B 103 0 SHEET 2 E 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 E 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 SHEET 1 F 5 SER B 121 ALA B 129 0 SHEET 2 F 5 THR B 111 TYR B 118 -1 N VAL B 114 O TYR B 126 SHEET 3 F 5 VAL B 148 ASP B 153 -1 O PHE B 150 N SER B 113 SHEET 4 F 5 CYS B 156 GLU B 166 -1 O CYS B 156 N ASP B 153 SHEET 5 F 5 VAL F 3 LEU F 4 -1 O VAL F 3 N GLU B 166 LINK SG CYS A 145 C 0JU E 5 1555 1555 1.67 LINK SG CYS B 145 C 0JU F 5 1555 1555 1.65 LINK C BOC E 1 N ALA E 2 1555 1555 1.33 LINK C LEU E 4 N 0JU E 5 1555 1555 1.33 LINK C BOC F 1 N ALA F 2 1555 1555 1.33 LINK C LEU F 4 N 0JU F 5 1555 1555 1.33 SITE 1 AC1 7 LYS A 5 TYR A 126 GLN A 127 LYS B 5 SITE 2 AC1 7 TYR B 126 GLN B 127 HOH B 583 SITE 1 AC2 3 THR A 35 SER A 81 ARG A 88 SITE 1 AC3 2 ASN A 84 HOH A 521 SITE 1 AC4 5 ARG B 105 ILE B 106 PRO B 108 TYR B 182 SITE 2 AC4 5 HOH B 509 SITE 1 AC5 5 ARG A 105 HIS A 134 GLY A 183 ASP B 245 SITE 2 AC5 5 ASP B 248 SITE 1 AC6 7 GLY A 11 LYS A 12 GLY B 11 GLU B 14 SITE 2 AC6 7 GLY B 15 LYS B 97 HOH B 594 SITE 1 AC7 7 HOH A 503 PRO B 108 GLU B 240 HIS B 246 SITE 2 AC7 7 HOH B 595 HOH B 597 HOH B 605 SITE 1 AC8 4 SER B 254 ALA B 260 VAL B 261 LEU B 262 SITE 1 AC9 6 ASP A 248 ASN B 133 PRO B 184 PHE B 185 SITE 2 AC9 6 ALA B 194 GLY B 195 SITE 1 BC1 15 LEU A 27 PHE A 140 LEU A 141 GLY A 143 SITE 2 BC1 15 CYS A 145 HIS A 163 HIS A 164 MET A 165 SITE 3 BC1 15 GLU A 166 PRO A 168 HIS A 172 GLN A 189 SITE 4 BC1 15 THR A 190 ALA A 191 GLN A 192 SITE 1 BC2 11 HIS B 41 PHE B 140 LEU B 141 CYS B 145 SITE 2 BC2 11 HIS B 163 HIS B 164 MET B 165 GLU B 166 SITE 3 BC2 11 GLN B 189 THR B 190 ALA B 191 CRYST1 52.322 97.103 67.405 90.00 103.17 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019112 0.000000 0.004472 0.00000 SCALE2 0.000000 0.010298 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015236 0.00000